Gene · 1066
Papers3,256
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,256
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Generation and application of CES1-knockout Tet-Off-regulated CYP3A4 and UGT1A1-expressing Caco-2 cells. | Toxicol Lett | 2024 | 39383894 | PubTator, text mining | PubMed |
| CYP P450 and non-CYP P450 Drug Metabolizing Enzyme Families Exhibit Differential Sensitivities towards Proinflammatory Cytokine Modulation. | Drug Metab Dispos | 2024 | 39349298 | PubTator, text mining | PubMed |
| Brain Exposure to the Macrocyclic ALK Inhibitor Zotizalkib is Restricted by ABCB1, and Its Plasma Disposition is Affected by Mouse Carboxylesterase 1c. | Mol Pharm | 2024 | 39312722 | PubTator, text mining | PubMed |
| Fluorogenic chemical tools to shed light on CES1-mediated adverse drug interactions. | Chem Commun (Camb) | 2024 | 39279555 | PubTator, text mining | PubMed |
| Increased serum carboxylesterase-1 levels are associated with metabolic dysfunction associated steatotic liver disease and metabolic syndrome in children with obesity. | Ital J Pediatr | 2024 | 39227971 | PubTator, text mining | PubMed |
| Evaluating the operational properties of concrete admixtures containing molecularly modified polycarboxylate superplasticizers. | Sci Rep | 2024 | 39215147 | PubTator, text mining | PubMed |
| The activation cascade of the broad-spectrum antiviral bemnifosbuvir characterized at atomic resolution. | PLoS Biol | 2024 | 39190717 | Swiss-Prot, curated | PubMed |
| Carboxylesterase 1-Based Drug-Drug Interaction Potential of Remimazolam: In-Vitro Studies and Literature Review. | Curr Drug Metab | 2024 | 39108117 | PubTator, text mining | PubMed |
| Integrated multi-omics profiling landscape of organising pneumonia. | Clin Transl Med | 2024 | 39083563 | PubTator, text mining | PubMed |
| The ester-containing prodrug NT-0796 enhances delivery of the NLRP3 inflammasome inhibitor NDT-19795 to monocytic cells expressing carboxylesterase-1. | Biochem Pharmacol | 2024 | 39069136 | PubTator, text mining | PubMed |
| Genetic variants of ABCB1 and CES1 genes on dabigatran metabolism in the Kazakh population. | Caspian J Intern Med | 2024 | 39011438 | PubTator, text mining | PubMed |
| Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer. | J Transl Med | 2024 | 38982444 | PubTator, text mining | PubMed |
| Discovery of a novel homocysteine thiolactone hydrolase and the catalytic activity of its natural variants. | Protein Sci | 2024 | 38980003 | PubTator, text mining | PubMed |
| Pyrazolone compounds could inhibit CES1 and ameliorates fat accumulation during adipocyte differentiation. | Bioorg Chem | 2024 | 38878751 | PubTator, text mining | PubMed |
| Characterisation of ciclesonide metabolism in human placentae across gestation. | Placenta | 2024 | 38875771 | PubTator, text mining | PubMed |
| Carboxylesterase 1 directs the metabolic profile of dendritic cells to a reduced inflammatory phenotype. | J Leukoc Biol | 2024 | 38869086 | PubTator, text mining | PubMed |
| Drug-Drug Interaction Potential of Remimazolam: CYP 450, Transporters, and Protein Binding. | Curr Drug Metab | 2024 | 38818914 | PubTator, text mining | PubMed |
| Gene polymorphism as a cause of hemorrhagic complications in patients with non-valvular atrial fibrillation treated with oral vitamin K-independent anticoagulants. | Ther Adv Cardiovasc Dis | 2024 | 38801157 | PubTator, text mining | PubMed |
| Regulation of Human Hydrolases and Its Implications in Pharmacokinetics and Pharmacodynamics. | Drug Metab Dispos | 2024 | 38777597 | PubTator, text mining | PubMed |
| Sterol O-acyltransferase (SOAT/ACAT) activity is required to form cholesterol crystals in hepatocyte lipid droplets. | Biochim Biophys Acta Mol Cell Biol Lipids | 2024 | 38761895 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1066/papers?page=10